Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of AVTX-009 in moderate to severe hidradenitis suppurativa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• AVTX-009

Snippet

Sponsor: Avalo Therapeutics, Inc. | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED